Alveolar type II cell apoptosis

Comparative Biochemistry and Physiology - A Molecular and Integrative Physiology

Volumn 129, Issue 1, 2001, Pages 267-285

  Sutherland, Leanne M ^a   Edwards, Yasmin S ^a   Murray, Andrew W ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

Alveolar type II cell; Apoptosis; Lung injury

Indexed keywords

LUNG SURFACTANT;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; HUMAN; LUNG ALVEOLUS CELL TYPE 2; LUNG DISEASE; PROTEIN LIPID INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; STEM CELL;

EID: 0034999614     PISSN: 10956433     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1095-6433(01)00323-3     Document Type: Conference Paper

References (122)

1. Akita K., Ohtsuki T., Nakada Y. Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells. J. Biol. Chem. 272:(42):1997;26595-26603.
2. Allen R.T., William J.H. III, Agrawal D.K. Morphological and biochemical characterisation of apoptosis. J. Pharm. Toxicol. Meth. 37:1997;215-228.
3. Antus B., Mucsi I., Rosivall L. Apoptosis and inhibition of cellular proliferation by angiotensin II: possible implication and perspective. Acta. Physiol. Hung. 87:2000;5-24.
4. Aoshiba K., Yasui S., Tamaoki J., Nagai A. The Fas/Fas-ligand system is not required for bleomycin-induced pulmonary fibrosis in mice. Am. J. Crit. Care Med. 162:2000;695-700.
5. Ashkenazi A., Dixit V.M. Death receptors: signalling and modulation. Science. 281:1998;1305-1308.
6. Barazzone C., Donati Y.R., Rochat A.F., Vesin C., et al. Keratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in mice. Am. J. Pathol. 154:1999;1479-1487.
7. Bardales R.H., Xie S-S., Schaefer R.F., Hsu S-M. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury. Am. J. Pathol. 149:1996;845-852.
8. Billiar T.R. Nitric oxide. Novel biology with clinical relevance. Ann. Surg. 221:1995;339-349.
9. Borok Z., Danto S.I., Lubman Y.C., Williams M.C., Crandall E.D. Modulation of T1-α expression with alveolar epithelial cell phenotype in vitro. Am. J. Physiol. 275:1998;L155-L164.
10. Brown L.S., Harris F.L., Jones D.P. Ascorbate deficiency and oxidative stress in the alveolar type II cell. Am. J. Physiol. 273:1997;L782-L788.
11. 2-exposed rat lung. Am. J. Physiol. 268:1995;L455-464.
12. Buckley S., Barsky L., Driscll B., Weinberg K., Anderson K.D., Warburton D. Apoptosis and DNA damage in type 2 alveolar epithelial cells cultured from hyperoxic rats. Am. J. Physiol. 274:1998;L714-L720.
13. Buckley S., Driscll B., Barsky L., Weinberg K., Anderson K.D., Warburton D. ERK activation protects against DNA damage and apoptosis in hyperoxic rat AEC2. Am. J. Physiol. 277:1999;L159-L166.
14. Budihardjo I., Holt O., Lutter M., Lou X., Wang X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15:1999;269-290.
15. Buettner G.R., Jurkiewicz B.A. Chemistry and biochemistry of ascorbic acid. Cadenas E., Packer L. Handbook of Antioxidants. 1996;91-115 Dekker, New York.
16. Burri P.H., Moschopules M. Structural analysis of fetal rat lung development. Nat. Rec. 234:1992;399-418.
17. Cappelletti C., Maggioni M.G., Maci R. Apoptosis in human lung epithelial cells triggered by paraquat and modulation by antioxidants. Cell Biol. Int. 22:(9/10):1998;671-678.
18. Chao D.T., Korsmeyer S.J. BCL-2 FAMILY: regulators of cell death. Annu. Rev. Immunol. 16:1998;395-419.
19. Chen X., Ko L.J., Jayaraman L., Prives C. p53 levels, functional domains, and DNA damage determined the extent of the apoptotic response of tumor cells. Genes Dev. 10:1996;2438-2451.
20. Chess P.R., Toia L., Finkelstein J.N. Mechanical strain-induced proliferation and signalling in pulmonary epithelial H441 cells. Am. J. Physiol. 279:2000;L43-L51.
21. Crouch E.C., Martin G.R., Brody J.S. Basement membranes. Crystal R.G., West J.B. The Lung: Scientific Foundations. 1991;421-427 Raven, New York.
22. Danto S.I., Shannon J.M., Borok Z., Zabski S.M., Crandell E.D. Reversible transdifferentiation of alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 12:(5):1995;497-502.
23. De Paepe M.E., Sardesai M.P., Johnson B.D., Lesieur-Brooks A.M., Papadakis K., Luks F.I. The role of apoptosis in normal and accelerated lung development in fetal rabbits. J. Pediatr. Surg. 34:1999;863-871.
24. Deterding R.R., Yanos R.T., Havill A.M., et al. Keratinocyte growth factor prevents bleomycin lung injury in rats. Am. J. Respir. Crit. Care Med. 151:1995;A198.
25. Deterding R.R., Havill A.M., Yano T. Prevention of bleomycin-induced lung injury in rats by keratinocyte growth factor. Proc. Assoc. Am. Phys. 109:(3):1997;254-268.
26. Devereux T.R., Hook G.E.R., Fouts J.R. Foreign compound metabolism by isolated cell from rat lung. Drug Metab. Dispos. 7:1979;70-75.
27. Dobbs L.G., Williams M.C., Brandt A.E. Changes in biochemical characteristics and pattern of alveolar type II cells with time in culture. Biochem. Biophys. Acta. 846:1985;155-166.
28. Dobbs L.G., Pian M.S., Maglio M., Dumars S., Allan L. Maintenance of the differentiated type II cell phenotype by culture with an apical air surface. Am. J. Physiol. 273:1997;L347-L354.
29. Earnshaw W.C., Martins L.M., Kaufmann S.C. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68:1999;383-424.
30. Edwards Y.S., Sutherland L.M., Power J.H.T., Nicholas T.E., Murray A.W. Osmotic stress induces both secretion and apoptosis in rat alveolar type II cells. Am. J. Physiol. 275:1998;L670-L678.
31. Edwards Y.S., Sutherland L.M., Murray A.W. Cyclic stretch induces both apoptosis and secretion in rat alveolar type II cells. FEBS Lett. 448:1999;127-130.
32. Edwards, Y.S., Sutherland, L.M., Murray, A.W., In press. Nitric oxide protects alveolar type II cell from stretch-induced apoptosis. A novel role for macrophages in the lung. Am. J. Physiol.
33. El-Deiry W.S., Tokino T., Veluclescu V.E., et al. WAF1, a potential mediator of p35 tumor suppression. Cell. 75:1993;817-825.
34. Fehrenbach H., Kasper M., Tschernig T., et al. Keratinocyte growth factor-induced hyperplasia of rat type II cells in vivo is resolved by differentiation into type I cells and apoptosis. Eur. Respir. J. 14:1999;534-544.
35. Fehrenbach H., Kasper M., Koslowski R., et al. Alveolar epithelial type II cell apoptosis in vivo during resolution of keratinocyte growth factor-induced hyperplasia in the rat. Histochem. Cell Biol. 114:(1):2000;49-61.
36. Fine A., Anderson N.L., Rothstein T.L., Williams M.C., Gochuico B.R. Fas expression in pulmonary alveolar type II cells. Am. J. Physiol. 273:1997;L64-L71.
37. Flecknoe S., Harding R., Maritz G., Hooper S.B. Increased lung expansion alters the proportions of type I and type II alveolar epithelial cells in fetal sheep. Am. J. Physiol. 27:2000;L1180-L1185.
38. Friederlander P., Haupt Y., Prives C., Oren M. A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis. Mol. Cell Biol. 16:1996;4961-4971.
39. Grasl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., Bulowska K., Bursch W., Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note. Hepatology. 21:1995;465-1468.
40. Griffin M., Bhandari R., Hamilton G., Chan Y-C., Powell J.T. Alveolar type II cell-fibroblast interactions, synthesis and secretion of surfactant and type I collagen. J. Cell Sci. 105:1993;423-432.
41. Guinee D., Fleming M., Hayashi T., et al. Association of p54 and WAF1 expression with apoptosis in diffuse alveolar damage. Am. J. Pathol. 149:(2):1996;531-538.
42. Guinee D., Brambilla E., Fleming M., et al. The potential role of BAX and BCL-2 expression in diffuse alveolar damage. Am. J. Pathol. 151:(4):1997;999-1007.
43. Guo J., Yi E.S., Havill A.M., et al. Intravenous keratinocyte growth factor protects against experimental pulmonary injury. Am. J. Physiol. 275:1998;800-805.
44. Haddad J.J.E., Land S.C. The differential expression of apoptosis factors in the alveolar epithelium is redox sensitive and requires NF-κB (RelA)-selective targeting. Biochem. Biophys. Res. Commun. 271:2000;257-267.
45. Haddad J.J.E., Oliver R.E., Land S.C. Antioxidant/Pro-oxidant equilibrium regulates HIF-1α and NF-κB redox sensitivity. J. Biol. Chem. 275:(28):2000;21130-21139.
46. Hagimoto N., Kuwano K., Nomoto Y., Kunitaje R., Hara N. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am. J. Respir. Cell. Mol. Biol. 16:1997;91-101.
47. Hagimoto N., Kuwano K., Miyazaki H., et al. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am. J. Respir. Cell. Mol. Biol. 17:1997;272-278.
48. Harmon K.R., Marinelli W.W., Henke C.A., Bitterman P.B. Regulation of Cell Replication. Crystal R.G., West J.B. The Lung: Scientific Foundations. 1991;105-129 Raven, New York.
49. Harper J.W., Adami G.R., Wei K., Keryomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 74:1993;805-816.
50. Hastings R.H., Berg J.T., Summers-Torres D., Burton D.W., Deftos L.T. Parathyroid hormone-related protein reduces alveolar epithelial cell proliferation during lung injury in rats. Am. J. Physiol. 279:2000;L194-L200.
51. Hastings R.H., Summers-Torres D., Yaszay B., LeSueur J., Burton D.W., Deftos L.T. Parathyroid hormone-related protein, an autocrine growth inhibitor of alveolar type II cells. Am. J. Physiol. 27:1997;L394-L399.
52. Hastings R.H., Summers-Torres D., Burton D.W., Deftos L.T. Growth factor control of type II cell apoptosis. Chest. 116:1999;68.
53. Herberlein W., Wodopia R., Bärtsch P., Mairbäurl H. Possible role of ROS as mediators of hyperoxia-induced ion transport inhibition of alveolar epithelial cells. Am. J. Physiol. 278:2000;L640-L648.
54. Howlett C.E., Hutchison J.S., Veinot J.P., Chiu A., Merchant P., Fliss H. Inhaled nitric oxide protects against hyperoxic-induced apoptosis in rat lungs. Am. J. Physiol. 277:1999;596-605.
55. Janssen Y.M.W., Soultanakis R., Steece K., et al. Depletion of nitric oxide causes cell cycle alterations, apoptosis, and oxidative stress in pulmonary cells. Am. J. Physiol. 275:1998;L1100-L1109.
56. Jones K.J., Holland J.F., Foureman G.L., Fouts J.R. Xenobiotic metabolism in Clara cells and alveolar type II cells isolated from lungs of rats treated with beta-naphthoflavone. J. Pharmacol. Exp. Ther. 225:1983;316-319.
57. Kazzaz J., Xu J., Palaia T.A., Mantell L., Fein A.M., Horowitz S. Cellular oxygen toxicity. J. Cell Biol. 271:(25):1996;15182-15186.
58. Khalil N., Bereznay O., Sporn M., Greenberg A.H. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 170:1989;727-737.
59. Kim Y-M., Talanian R.V., Billiar T.R. Nitric oxide inhibits apoptosis by preventing increases in caspase-3 activity via two distinct mechanisms. J. Biol. Chem. 272:1997;31138-31148.
60. Koyama S., Sato E., Nomura H., Kubo K., et al. Bradykinin stimulates type II alveolar cells to release neutrophil and monocyte chemotatic activity and inflammatory cytokines. Am. J. Pathol. 153:(6):1998;1883-1893.
61. Kuwano K., Kunitake R., Kawasaki M., et al. p21 Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care. Med. 154:(2):1996;477-483.
62. Kuwano K., Miyazaki H., Hagimoto N., et al. The involvement of Fas-Fas ligand pathway in fibrosing lung disease. Am.J. Respir. Cell Mol. Biol. 20:1999;53-60.
63. Kuwano K., Hagimoto N., Tanka T., et al. Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice. J. Pathol. 190:2000;221-229.
64. Kyriakis J.M., Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271:1996;24313-24316.
65. Lee Y.C., Chen K.T., Lee H.B., Rhee Y.K., Kim D.S. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with asthma. Allergy. 55:2000;959-963.
66. Li N., Karin M. Is NF-κB the senor of oxidative stress? FASEB J. 13:1999;1137-1143.
67. Li Y., Zhang W., Mantell L.L., Fein A.M., Horowitz S. Nuclear factor-κB is activated by hyperoxia but does not protect from cell death. J. Cell Biol. 272:(33):1997;20646-20649.
68. Li H., Zhu H., Xu C.J., Yaun J. Cleavage of Bid by caspase-8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
69. Lou X., Budihardjo I., Slaughter C., Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1994;491-501.
70. Mariani T.J., Dunsmore S.E., Li Q., Ye X., Pierce R.A. Regulation of lung fibroblast tropoelastin expression by alveolar epithelial cells. Am. J. Physiol. 274:1998;L47-L57.
71. Mason R.J., Shannon J.M. Alveolar Type II cells. Crystal R.G., West J.B. The Lung: Scientific Foundations. 1997;543-555 Raven, New York.
72. + channels in alveolar epithelial cells. Am. J. Physiol. 271:1996;L1-L22.
73. Matute-Bello G., Winn R.K., Jonas E., Chi Y., Martin T.R., Liles W.C. Activation of Fas (CD95) induces lung injury and apoptosis of type I and II pneumonocytes. Am. J. Respir. Crit. Care Med. 159:1999;A697.
74. Matute-Bello G., Liles W.C., Steinberg K.P., et al. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury. J. Immunol. 163:1999;2217-2225.
75. Mori I., Komatsu T., Takeuchi K., Sudo M., Kimura Y. In vivo induction of apoptosis by influenza virus. J. Gen. Virol. 76:1995;2869-2873.
76. Murray J.F., Matthay M.A., Luce J.M., Flick M.R. An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138:1998;720-723.
77. Nathan D.F., Prendergast T.J., Wiebe M.E., et al. Activation of human macrophages. Comparisons of other cytokines with interferon gamma. J. Exp. Med. 160:1984;600-605.
78. Nicholson D.W. ICE/CED-3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nat. Biotech. 14:1996;297-301.
79. O'Brien A.D., Standiford T.J., Christensen P.J., Wilcoxen S.E., Paine R III. Chemotaxis of alveolar macrophages in response to signals derived from alveolar epithelial cells. J. Lab. Clin. Med. 131:(5):1998;417-424.
80. O'Reilly M., Staversky R.J., Watkins R.H., Maniscalco W.M., Keng P.C. p53-independent induction of GADD 45 and GADD153 in mouse lungs exposed to hyperoxia. Am. J. Physiol. 278:2000;L552-L559.
81. Paine R III, Rolfe M.W., Standiford T.J., Burdick M.D., Rollins B.J., Strieter R.M. MCP-1 expression by rat type II alveolar epithelial cells in primary culture. J. Immunol. 150:(10):1993;4561-4570.
82. Pallardy M., Biola A., Lebrec H., Bréard J. Assessment of apoptosis in xenobiotic-induced immunotoxicity. Methods. 19:1999;36-47.
83. Panos R.J., Rubin J.S., Csaky K.G., Aaronson S.A., Mason R.J. Keratinocyte growth factor and hepatocyte growth factor scatter factor are heparin-binding factors for alveolar type II cells in fibroblast conditioned medium. J. Clin. Invest. 92:1993;677-696.
84. Panos R.J., Bak P.M., Simonet W.S., Rubin J.S., Smith I.J. Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats. J. Clin. Invest. 96:1995;2026-2033.
85. Peterkofsky B. Ascorbate requirement for hydroxylation and secretion of procollagen: relationship to inhibition of collagen synthesis in scurvy. Am. J. Clin. Nutr. 54:1991;1135S-1140S.
86. Phan S.H., Kunkel S.L. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp. Lung Res. 18:1992;29-43.
87. Proud D. Production and metabolism of kinnins. Crystal R.G., West J.B. The Lung: Scientific Foundations. 1991;61-68 Raven, New York.
88. Quinn D., Tager A., Joseph P.M., Bonoventre J.V., Force T., Hales C.A. Stretch-induced mitogen-activated protein kinase activation and interleukin-8 production in type II alveolar cells. Chest. 116:(1):1999;89S-90.
89. Rahman I., MacNee W. Lung glutathione: implications in cigarette smoke-induced airway disease. Am. J. Physiol. 277:1999;L1067-1088.
90. Rodman D.M., Voelkel N.F. Regulation of vascular tone. Crystal R.G., West J.B. The Lung: Scientific Foundations. 1991;1105-1119 Raven, New York.
91. Rose M.S., Smith L.L., Wyatt I. Evidence for energy-dependent accumulation of paraquet into rat lung. Nature. 252:1974;314-315.
92. Sadoshima J-I., Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac monocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 12:(4):1993;1681-1692.
93. Salva U., Waters C.M. Mechanical strain inhibits repair of airway epithelium in vitro. Am. J. Physiol. 274:2000;L883-L892.
94. Saraste A., Pulkki K. Morphological and biochemical hallmarks of apoptosis. Cardiovasc. Res. 45:2000;528-537.
95. Scavo L.M., Ertsey R., Chapin C.J., Allen L., Kitterman J.A. Apoptosis in the development of rat and human fetal lungs. Am. J. Respir. Cell Mol. Biol. 18:1998;21-31.
96. Schittney J.C., Djonov V., Fine A., Burri P.H. Programmed cell death contributes to postnatal lung development. Am. J Respir. Cell Mol. Biol. 18:1998;786-793.
97. Shannon J.M., Jennings S.D., Nielsen L.D. Modulation of alveolar type II cell differentiated function in vitro. Am. J. Physiol. 262:1992;L427-L436.
98. Sheikh M.S., Chen Y.Q., Smith M.L., Fornace A.J. Role of p21/Waf/Cip/Sdi1 in cell death and DNA repair as studied using a tetracyclin-inducible system in p53-deficient cells. Oncogene. 14:1997;1875-1882.
99. Slutsky A. Lung injury caused by mechanical ventilation. Chest. 116:(1):1999;9S-15.
100. Smith R.M., Spragg R.G. The lung in the intensive care unit. Crystal R.G., West J.B. The Lung: Scientific Foundations. 1991;2185-2196 Raven, New York.
101. Smith M.L., Chen I.T., Zhan Q. Jr., et al. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science. 266:1994;1376-1380.
102. Spragg R.G., Smith R.M. Biology of Acute Lung Injury. Crystal R.G., West J.B. The Lung: Scientific Foundations. 1991;2003-2017 Raven, New York.
103. Suzuki Y.J., Forman H.J., Sevanian A. Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 22:1997;269-385.
104. Takeoka M., Ward W.F., Pollack H., Kamp D.W., Panos R.J. KGF facilitates repair of radiation-induced DNA damage in alveolar type II cells. Am. J. Physiol. 272:1997;L1174-1180.
105. Tesfaigzi J., Wood M.B., Johnson N.F., Nikula K. Apoptosis is a pathway responsible for the resolution of endotoxin-induced alveolar type II cell hyperplasia in the rat. Int. J. Exp. Pathol. 79:1998;303-311.
106. Thornberry N.A., Bull H.G., Calaycay J.R., et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 356:1992;768-774.
107. Tschumperlin D.J., Margulies S.S. Equibiaxial deformation-induced injury of alveolar epithelial cells in vitro. Am. J. Physiol. 275:1998;L1173-L1183.
108. Uhal B.H. Cell cycle kinetics in the alveolar epithelium. Am. J. Physiol. 272:1997;L1031-L1045.
109. Uhal B.D., Joshi I., True A., et al. Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. Am. J. Physiol. 269:1995;L819-L828.
110. Ulich T.R., Lomgmuir K., Blitz R., Morris C.F., Housley R.M., Pierce G.F. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J. Clin. Invest. 93:(3):1994;1298-1306.
111. Walker P.R., Weaver V.M., Lach B., LeBlanc J., Sikorska M. Endonuclease activities with high molecular weight and internucleosomal DNA fragmentation in apoptosis. Exp. Cell Res. 213:1994;100-106.
112. Uhal B.D., Joshi I., Hughes F., Ramos C., Pardo A., Selman M. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am. J. Physiol. 275:1998;L1192-L1199.
113. Wang R., Ramos C., Joshi I., et al. Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis as angiotensin peptides. Am. J. Physiol. 277:1999;L1158-L1164.
114. Wang R., Zagariya A., Ibarra-Sunga O., et al. Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am. J. Physiol. 276:1999;L885-L889.
115. Wang R., Zagariya A., Ang E., Ibarra-Sunga O., Uhal B.D. Fas-induced apoptosis of alveolar epithelial cell requires ANG II generation and receptor interaction. Am. J. Physiol. 277:1999;1245-1250.
116. Wang R., Alam G., Zagariya A., et al. Apoptosis of lung epithelial cells in response to TNF-α requires angiotensin II generation de novo. J. Cell. Physiol. 185:(2):2000;253-259.
117. Wang R., Ibarra-Sunga O., Verlinski L., Pick R., Uhal B.D. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am. J. Physiol. 279:2000;143-151.
118. Wen L-P., Mandani K., Fahrni J.A., Duncan S.R., Rosen G.D. Dexamethasone inhibits lung epithelial cell apoptosis induced by INF-γ and Fas. Am. J. Physiol. 273:1997;L921-L929.
119. Widmann C., Gibson S., Jarpe M.B., Johnson G.L. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79:1999;143-180.
120. Witschi H. Responses of the lung to toxic injury. Environ. Health Perspect. 85:1990;5-13.
121. Wolfe J.T., Prinzle J.T., Cohen G.M. Cotter T.G., Martin S.J. Techniques in Apoptosis - A User's Guide. 1996;58-60 Portland Press, London.
122. 2 exposure. Am. J. Physiol. 275:1998;L780-L787.